|
Delayed
Nasdaq Stockholm
12:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 108.50 SEK | -1.27% |
|
-2.69% | +2.17% |
| 09-04 | Origo Seleqt rose 4.6 percent in August, invested in the Octave spin-off | FW |
| 08-31 | BioGaia Signs Distribution Deal with Recordati | MT |
Company Valuation: BioGaia AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 10,462 | 8,439 | 10,219 | 11,320 | 10,743 | 11,118 | - | - |
| Change | - | -19.33% | 21.1% | 10.77% | -5.09% | 3.48% | - | - |
| Enterprise Value (EV) 1 | 8,977 | 6,951 | 8,665 | 10,096 | 9,942 | 10,451 | 10,472 | 10,458 |
| Change | - | -22.57% | 24.67% | 16.51% | -1.52% | 5.12% | 0.21% | -0.13% |
| P/E | 53.3x | 22.6x | 28x | 32.2x | 32.3x | 28.7x | 23.4x | 20.7x |
| PBR | 5.57x | 4.28x | 5.03x | 6.57x | 8.18x | 8.55x | 8.29x | 7.85x |
| PEG | - | 0.3x | -12.95x | -8.33x | -5.92x | 1.8x | 1x | 1.5x |
| Capitalization / Revenue | 13.3x | 7.64x | 7.88x | 7.96x | 6.98x | 6.66x | 5.92x | 5.35x |
| EV / Revenue | 11.4x | 6.3x | 6.68x | 7.1x | 6.46x | 6.26x | 5.58x | 5.03x |
| EV / EBITDA | 31.9x | 18x | 18.5x | 20.2x | 22.7x | 20.2x | 16.6x | 14.6x |
| EV / EBIT | 35.4x | 19.2x | 19.6x | 23.8x | 24.1x | 21.3x | 17.4x | 15.2x |
| EV / FCF | 41.7x | - | - | - | 32.8x | 32x | 24.9x | 21.3x |
| FCF Yield | 2.4% | - | - | - | 3.05% | 3.12% | 4.02% | 4.7% |
| Dividend per Share 2 | 0.726 | 1.45 | 1.9 | 6.9 | 4 | 2.95 | 3.2 | 6 |
| Rate of return | 0.7% | 1.74% | 1.88% | 6.17% | 3.77% | 2.68% | 2.91% | 5.46% |
| EPS 2 | 1.944 | 3.7 | 3.62 | 3.48 | 3.29 | 3.825 | 4.69 | 5.32 |
| Distribution rate | 37.3% | 39.2% | 52.5% | 198% | 122% | 77.1% | 68.2% | 113% |
| Net sales 1 | 785.1 | 1,104 | 1,297 | 1,423 | 1,538 | 1,670 | 1,876 | 2,078 |
| EBITDA 1 | 281 | 385.3 | 468.4 | 500.1 | 437.1 | 518 | 630 | 717.5 |
| EBIT 1 | 253.7 | 361.5 | 443.1 | 423.4 | 412.5 | 489.5 | 601 | 686.5 |
| Net income 1 | 196.3 | 373.6 | 365.4 | 351.4 | 332.8 | 387 | 474 | 538 |
| Net Debt 1 | -1,485 | -1,488 | -1,554 | -1,224 | -801.3 | -667 | -645.5 | -659.5 |
| Reference price 2 | 103.60 | 83.57 | 101.20 | 111.90 | 106.20 | 109.90 | 109.90 | 109.90 |
| Nbr of stocks (in thousands) | 100,982 | 100,982 | 100,982 | 101,162 | 101,162 | 101,162 | - | - |
| Announcement Date | 2/4/22 | 2/3/23 | 2/7/24 | 2/12/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.73x | 6.26x | 20.18x | 2.68% | 1.16B | |
| 18.7x | 4.34x | 10.2x | 0.48% | 80.65B | |
| 20.24x | 4.32x | 13.42x | 2.43% | 59.12B | |
| -16.13x | 24.03x | -15.6x | -.--% | 54.14B | |
| 35.37x | 12.04x | 23.09x | -.--% | 50.1B | |
| 20.44x | 4.52x | 12.88x | 0.71% | 45.33B | |
| 36.39x | 3.45x | 13.17x | -.--% | 31.14B | |
| 56.23x | 3.59x | 27.79x | -.--% | 25.54B | |
| 65.36x | 6.91x | 42.04x | -.--% | 21.8B | |
| 23.23x | 4.99x | 12.99x | -.--% | 16.06B | |
| Average | 28.86x | 7.45x | 16.01x | 0.63% | 38.5B | |
| Weighted average by Cap. | 23.19x | 8.19x | 12.41x | 0.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIOG B Stock
- Valuation BioGaia AB
Select your edition
All financial news and data tailored to specific country editions
